I looked at about the last 15-20 posts of yours. Not much help. I get you are down on the stock, you don't think any catalysts are on the horizon and Perleman has been futilely propping up the stock.
I appreciate that but those are basically conclusions. I trying to understand the WHY. Why was the recent trial which seemed positive actually result in a significant decrease in SP?
Clinical trial results drive pharmaceuticals. If it's not going up on good trial news, it's hard to see it going up at all. So what am I missing?
News 
Market Data 
Discover 
